Published in Am J Pathol on July 01, 1989
Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol (1994) 7.36
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol (2000) 2.75
Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci U S A (1992) 2.30
Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol (1990) 1.86
Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest (1993) 1.58
Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science (2014) 1.49
High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest (1994) 1.22
Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol (1990) 1.08
Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells (2012) 1.00
Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol (1995) 0.95
Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J Clin Invest (1995) 0.92
CXCR4 enhances engraftment of muscle progenitor cells. Muscle Nerve (2009) 0.92
Bone marrow side population cells are enriched for progenitors capable of myogenic differentiation. J Cell Sci (2008) 0.91
Biological approaches to improve skeletal muscle healing after injury and disease. Birth Defects Res C Embryo Today (2012) 0.91
Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs. Mol Ther (2008) 0.90
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89
Inhibition of CD26/DPP-IV enhances donor muscle cell engraftment and stimulates sustained donor cell proliferation. Skelet Muscle (2012) 0.87
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells. Stem Cell Reports (2015) 0.87
The fate of dystrophin during the degeneration and regeneration of the soleus muscle of the rat. Acta Neuropathol (1992) 0.86
Expression and function of heterotypic adhesion molecules during differentiation of human skeletal muscle in culture. Am J Pathol (1992) 0.86
Long-term survival of transplanted stem cells in immunocompetent mice with muscular dystrophy. Am J Pathol (2008) 0.86
Lysis of myotubes by alloreactive cytotoxic T cells and natural killer cells. Relevance to myoblast transplantation. J Clin Invest (1990) 0.85
In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression. Am J Pathol (2005) 0.84
Transplantation of fetal cells and tissue: an overview. CMAJ (1994) 0.83
Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice. Am J Pathol (1991) 0.79
A high-content, high-throughput siRNA screen identifies cyclin D2 as a potent regulator of muscle progenitor cell fusion and a target to enhance muscle regeneration. Hum Mol Genet (2013) 0.77
Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control. Mol Biol Cell (1993) 0.76
Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice. Acta Neuropathol (1995) 0.76
The Need for a Consensus on the Locution "Central Nuclei" in Striated Muscle Myopathies. Front Physiol (2016) 0.75
Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell (1987) 20.27
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75
X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A (1984) 8.35
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (1989) 4.08
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
Immunoelectron microscopic localization of dystrophin in myofibres. Nature (1988) 3.37
Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature (1988) 3.25
Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve (1988) 1.98
Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science (1988) 1.70
Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve (1988) 1.67
THE FORMATION OF HYBRID MULTINUCLEATED MUSCLE FIBERS FROM MYOBLASTS OF DIFFERENT GENETIC ORIGIN. Dev Biol (1965) 1.62
Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve (1985) 1.27
Developmental regulation of cell-surface glycoproteins in clonal cultures of human skeletal muscle satellite cells. Biochem Cell Biol (1989) 0.86
Catastrophic shifts in ecosystems. Nature (2001) 25.57
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol (1998) 4.41
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects. J Neurosci (1996) 3.21
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat Genet (1995) 2.76
AIDS serology testing in low- and high-risk groups. JAMA (1985) 2.74
A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. Anesthesiology (1991) 2.67
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
The selective inhibition of macrophage phagocytic receptors by anti-membrane antibodies. J Exp Med (1972) 2.51
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51
Proximal axonal enlargement in motor neuron disease. Neurology (1968) 2.48
Physical separation of hemopoietic stem cells from cells forming colonies in culture. J Cell Physiol (1969) 2.46
Nonsexual transmission of sexually transmitted diseases: an infrequent occurrence. Pediatrics (1984) 2.44
Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study. Muscle Nerve (1990) 2.41
Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol (1999) 2.39
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature (1990) 2.20
Prevalence of pre-cancerous lesions and cervical cancer in South Africa--a multicentre study. S Afr Med J (2002) 2.13
Identification of a cadherin cell adhesion recognition sequence. Dev Biol (1990) 2.11
Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol (1993) 2.08
Late-onset mitochondrial myopathy. Ann Neurol (1995) 1.98
Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med (1990) 1.98
Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol (1988) 1.94
A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care (2001) 1.89
Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3. Genomics (1989) 1.87
Chromosome stability in CHO cells. Somatic Cell Genet (1977) 1.86
Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science (1984) 1.85
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction. Mol Cell Biol (1981) 1.80
Polarized angular dependent spectroscopy of epithelial cells and epithelial cell nuclei to determine the size scale of scattering structures. J Biomed Opt (2002) 1.78
Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci (1990) 1.78
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics (1991) 1.77
Karyotyping. Methods Enzymol (1979) 1.75
Partial gene duplication as a cause of human disease. Hum Mutat (1992) 1.73
Comparative proteome analysis of Helicobacter pylori. Mol Microbiol (2000) 1.73
Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Exp Neurol (2008) 1.67
Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve (1988) 1.67
Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1. J Virol Methods (2007) 1.66
Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology (1978) 1.65
Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci (1984) 1.65
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet (1984) 1.64
Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol (1990) 1.64
Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells. Mol Cell Biol (1987) 1.61
Functional inactivation of bacteriophage lambda morphogenetic gene in RNA. Nature (1975) 1.60
Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol (2000) 1.59
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Prevalence of antibody to hepatitis C virus in a blood donor population. Transfusion (1991) 1.57
Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Kufs' disease: a critical reappraisal. Brain (1988) 1.55
Primary care: core values developing primary care: gatekeeping, commissioning, and managed care. BMJ (1998) 1.55
Structural requirements for association of neurofascin with ankyrin. J Biol Chem (1998) 1.53
Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol (1990) 1.53
Molecular analysis of a constitutional X-autosome translocation in a female with muscular dystrophy. Science (1987) 1.53
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J (1991) 1.53
Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet Rec (2007) 1.52
Specific involvement of muscle, nerve, and skin in late infantile and juvenile amaurotic idiocy. Neurology (1972) 1.51
Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50
Linkage of genetic markers emt and chr in Chinese hamster cells. Somatic Cell Genet (1980) 1.49
The role of an amygdalo-nigrostriatal pathway in associative learning. J Neurosci (1997) 1.48
How accurately are height, weight and leg length reported by the elderly, and how closely are they related to measurements recorded in childhood? Int J Epidemiol (2000) 1.48
Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene. Genomics (1989) 1.45
Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain (1979) 1.44
Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol (1993) 1.42
Subacute necrotizing encephalomyelopathy. A review and a study of two families. Brain (1971) 1.42
A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet (1994) 1.41
Combined central and peripheral myelinopathy. Neurology (1987) 1.40
Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families. Genomics (1990) 1.38
Atropine sulphate absorption in humans after intramuscular injection of a mixture of the oxime-P2S and atropine. Br J Pharmacol (1971) 1.38
Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. Science (1988) 1.38
The role of the subthalamic nucleus in response inhibition: evidence from deep brain stimulation for Parkinson's disease. Neuropsychologia (2009) 1.38
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology (1975) 1.38
Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med (1986) 1.37
Creutzfeldt-Jakob disease presenting as isolated aphasia. Neurology (1989) 1.36
Physical separation of hemopoietic stem cells differing in their capacity for self-renewal. J Exp Med (1969) 1.36
Direct-to-consumer genetic testing: good, bad or benign? Clin Genet (2009) 1.34
Giant axonal neuropathy. A clinically and morphologically distinct neurological disease. Arch Neurol (1974) 1.34
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet (1993) 1.33
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33